Your browser doesn't support javascript.
loading
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).
Rummel, M; Kim, T M; Aversa, F; Brugger, W; Capochiani, E; Plenteda, C; Re, F; Trask, P; Osborne, S; Smith, R; Grigg, A.
Afiliación
  • Rummel M; Department of Hematology & Oncology, University Hospital Giessen, Giessen, Germany.
  • Kim TM; Division of Hematology & Medical Oncology, Seoul National University Hospital, Seoul, South Korea.
  • Aversa F; University of Parma, Parma, Italy.
  • Brugger W; Schwarzwald-Baar Clinic Villingen-Schwenningen, Academic Teaching Hospital, University of Freiburg, Freiburg, Germany.
  • Capochiani E; Center for Hematology, Livorno, Italy.
  • Plenteda C; University of Parma, Parma, Italy.
  • Re F; University Hospital Parma, Parma, Italy.
  • Trask P; Genentech Inc., South San Francisco, USA.
  • Osborne S; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Smith R; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Grigg A; Department of Clinical Haematology, Austin Hospital, Heidelberg, Australia.
Ann Oncol ; 28(4): 836-842, 2017 04 01.
Article en En | MEDLINE | ID: mdl-28031173

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Folicular / Linfoma de Células B Grandes Difuso / Prioridad del Paciente / Rituximab / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma Folicular / Linfoma de Células B Grandes Difuso / Prioridad del Paciente / Rituximab / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article